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Abstract
Few studies have simultaneously evaluated delay discounting and behavioral economic demand to 
determine their unique contribution to drug use. A recent study in cannabis users found that 
monetary delay discounting uniquely predicted cannabis dependence symptoms, whereas cannabis 
demand uniquely predicted use frequency. This study sought to replicate and extend this research 
by evaluating delay discounting and behavioral economic demand measures for multiple 
commodities and including a use quantity measure. Amazon.com’s Mechanical Turk was used to 
sample individuals reporting recent cannabis use (n = 64) and controls (n = 72). Participants 
completed measures of monetary delay discounting as well as alcohol and cannabis delay 
discounting and demand. Cannabis users and controls did not differ on monetary delay discounting 
or alcohol delay discounting and demand. Among cannabis users, regression analyses indicated 
that cannabis delay discounting uniquely predicted use severity, whereas cannabis demand 
uniquely predicted use frequency and quantity. These effects remained significant after controlling 
for other delay discounting and demand measures. This research replicates previous outcomes 
relating delay discounting and demand with cannabis use and extends them by accounting for the 
contribution of multiple commodities. This research also demonstrates the ability of online 
crowdsourcing methods to complement traditional human laboratory techniques.
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1. Introduction
The marriage of behavioral economics with substance use research over the last three 
decades has advanced an understanding of the etiology and treatment of drug-taking 
behavior (Bickel et al., 2000; Chivers and Higgins, 2012; Hursh, 1984; MacKillop, 2016). 
Two of the most common applications of behavioral economics to drug use are delay 
discounting and behavioral economic demand. Delay discounting is the systematic reduction 
in value of a reinforcer as a function of the delay to its delivery (Green and Myerson, 2004; 
Odum, 2011; Rachlin and Green, 1972). Excessive delay discounting is thought central to 
substance use disorders and may represent a trans-disease process relating drug use to other 
maladaptive health behaviors (Bickel et al., 2012; Koffarnus et al., 2013). Several meta-
analyses support this assertion by demonstrating a robust relationship between delayed 
reward discounting and drug use severity, dependence, and quantity-frequency variables 
(Amlung et al., 2016; MacKillop et al., 2011). This literature also provides evidence for an 
association between delay discounting and treatment response across diverse clinical 
populations (e.g., Krishnan-Sarin et al., 2007; MacKillop and Kahler, 2009; Washio et al., 
2011; Yoon et al., 2007).
Substance use researchers have also situated drug use within a commodity purchase 
framework and used behavioral economic demand models to describe drug-taking behavior 
(e.g., Hursh, 1984, 1993; Johnson and Bickel, 2006). A recent popular extension of these 
methods is the commodity purchase task in which participants report hypothetical or 
realized commodity consumption across a range of prices per unit of the commodity (Jacobs 
and Bickel, 1999; MacKillop et al., 2008; Murphy et al., 2009). To date, purchase tasks have 
been successfully applied to a variety of drugs and drug classes, including alcohol, cannabis, 
cigarettes, cocaine, opioids, and synthetic cathinones (Amlung and MacKillop, 2015; Aston 
et al., 2015, 2016; Bruner & Johnson, 2014; Collins et al., 2014; Johnson and Johnson, 
2014; MacKillop et al., 2008; Murphy & MacKillop, 2006; Pickover et al., 2016). These 
studies have demonstrated that commonly used and misused substances follow the same 
prototypic patterns of consumption as other goods, including decreases in consumption with 
increases in price, and price ranges at which consumption is sensitive (i.e., elastic) or 
insensitive (i.e., inelastic) to price change. Such research has also helped reveal behavioral 
mechanisms by which putative interventions may decrease drug consumption (Bujarski et 
al., 2012; McClure et al., 2013) and prognostic variables predicting treatment success 
(MacKillop and Murphy, 2007; Murphy et al., 2015).
Despite being the most widely used illicit substance in the United States, cannabis has 
received comparatively little attention in the delay discounting and demand literatures. 
Further information on cannabis delay discounting and demand could be useful given the 
increasing number of states proposing or that have passed legalized recreational use, and the 
growing prevalence of cannabis use reported in the United States over the last decade 
(Center for Behavioral Health Statistics, 2016). Although many first-time or recreational 
users will not continue to regular use, others will progress to problematic usage patterns and 
seek treatment for cannabis use disorder. The application of behavioral economic theory 
could help identify behavioral mechanisms contributing to maladaptive use and hasten the 
design of preventative and therapeutic interventions.
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The association between delay discounting and cannabis use is more variable than for other 
drugs. For example, several studies have failed to show significant differences in delay 
discounting rates between cannabis users and controls (Johnson et al., 2010) or a 
relationship between delay discounting and treatment outcomes (Heinz et al., 2013; Peters et 
al., 2013; but see Stanger et al., 2012). However, others have demonstrated a role for delay 
discounting in aspects of cannabis use with significant associations observed between delay 
discounting and cannabis use initiation and severity (Aston et al., 2016; Bidwell et al., 2013; 
Heinz et al., 2013; Kollins, 2003). These differences in experimental outcomes could stem 
from the variations in the questions posed, namely delay discounting in cannabis users 
compared to controls as opposed to correlations between delay discounting and features of 
cannabis use (e.g., use severity). This limited literature also displays heterogeneity with 
respect to sample characteristics (e.g., college students versus treatment samples), delay 
discounting measures, and the commodity discounted. Such heterogeneity underscores the 
need for additional research to evaluate the association between delay discounting and 
aspects of cannabis, and to compare delay discounting rates between cannabis users and 
controls.
Cannabis demand has received even less attention than delay discounting, representing a 
research literature in its infancy. The few extant studies have revealed outcomes consistent 
with previous work with other drugs, such as a sensitivity of cannabis demand to increased 
cost and an expected relationship between cannabis demand and measures of cannabis use 
severity and frequency (Aston et al., 2015; Collins et al., 2014). These studies have also 
demonstrated changes in cannabis demand following manipulations affecting state 
disposition, with increases observed in cannabis demand after cannabis-cue presentation 
(Metrik et al., 2016).
Recent attempts have been made to unify the ideas of delay discounting and demand under a 
broader “reinforcer pathology” conceptualization of substance use (Bickel et al., 2011). This 
approach posits that substance use disorders are characterized by an extreme preference for 
immediate consumption of a drug reinforcer (i.e., delay discounting) combined with high 
valuation of that reinforcer (i.e., behavioral economic demand). Relatively little research, 
however, has simultaneously evaluated demand and delay discounting metrics despite their 
mutual importance for this and other theoretical models. In fact, only one study has done so 
in the context of cannabis use (Aston et al., 2016). Data in that study were combined from 
participants completing a delay discounting task for money following placebo smoked 
cannabis administration and a purchase task for hypothetical cannabis completed during a 
baseline screening session. Delay discounting and behavioral economic demand functioned 
as independent predictors, with monetary delay discounting uniquely predicting cannabis 
dependence (CD) symptom count and cannabis demand uniquely predicting frequency of 
cannabis use. However, this previous study only evaluated monetary delay discounting and 
cannabis demand. The inclusion of delay discounting and demand measures for multiple 
drug commodities (e.g., cannabis, alcohol) would help to demonstrate the specificity of 
cannabis-relevant outcomes for predicting use behaviors.
The purpose of the present study was to replicate and extend those findings relating delay 
discounting and demand to cannabis use behaviors. To this end, Amazon.com’s Mechanical 
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Turk (mTurk) was used to sample individuals reporting recent cannabis use. This study 
sought to extend previous research by 1) using an alternative sampling method allowing for 
greater demographic and drug use variability, 2) evaluating multiple commodities for delay 
discounting and demand variables, and 3) including a measure of use quantity (i.e., grams 
used per week) to further describe cannabis use patterns. Cannabis delay discounting was 
expected to uniquely predict CD symptom count and cannabis demand was expected to 
uniquely predict frequency and quantity of cannabis use. Alcohol delay discounting and 
demand were not expected to relate to cannabis use behaviors. As a secondary analysis, 
measures of delay discounting and behavioral economic demand were compared between 
cannabis users and non-cannabis using controls to add to the limited literature evaluating 
these outcomes between these groups. Significant differences between cannabis users and 
controls were not expected.
2. Methods
2.1 Participants and Procedures
Participants were sampled using mTurk where tasks are advertised as Human Intelligence 
Tasks (HITs). Participants were required to have a 95% or higher approval rating on all 
previously submitted mTurk HITs, over 100 approved HITs, and current residence in the 
United States to view the study HIT. The accuracy of these inclusion criteria was verified by 
the mTurk platform. Participants reviewed an informed consent document describing the 
study procedures, compensation, and the fact that anonymity would be retained throughout 
the study. All respondents indicated by electronic confirmation that they understood this 
document and agreed to participate. The University of Kentucky Institutional Review Board 
approved all protocols, including the consent process, and the protocol was carried out in 
accordance with the Declaration of Helsinki.
Participants completed the study tasks as a part of larger study on choice and decision-
making. A short screening questionnaire was used to determine if participants qualified for 
this study. Participants were only able to complete the screener once. Eligible participants 
were individuals reporting cannabis use during the past two weeks and 50 or more lifetime 
uses (n = 78). An additional control group was used to compare behavioral economic 
demand and delay discounting outcomes and included participants who did not report 
cannabis use in the past two weeks and five or fewer lifetime uses (n = 86). All participants 
were 18 years of age or older. Four attention checks were used to identify non-systematic, 
inattentive, or inconsistent participant data: 1) comparison of age and sex responses at the 
start and end of the survey, 2) recall at the end of the survey of a single digit number 
presented halfway through that participants were instructed to remember, 3) an item that 
instructed participants to select a specific response (i.e., “Select ‘A Little Bit’”), and 4) an 
item that asked participants if they had been attentive and thought their data should be 
included. Participants failing one or more checks were removed from data analysis, which 
resulted in a final sample size of 136 participants (cannabis users = 64; controls = 72). 
Demographic and drug use variables for cannabis users and controls are presented in Table 
1.
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2.2 Measures
2.2.1 5-Trial Adjusting Delay Task—A 5-trial adjusting delay task was used to evaluate 
delay discounting rates (for details see Koffarnus and Bickel, 2014). This task has been 
previously validated against traditional adjusting amount delay discounting tasks (Cox and 
Dallery, 2016; Koffarnus and Bickel, 2014). Participants were asked to select between some 
amount of a delayed commodity and half that amount available immediately. The delayed 
and immediate amounts remained constant while the delay to the larger amount was adjusted 
after each choice. The first choice was always at a three-week delay, which then adjusted up 
(longer delay following delayed choice) or down (shorter delay following immediate choice) 
based on decisions. The ED50, the inverse of the delay discounting rate or k, was determined 
following five choices and included 32 potential values between 1 hour and 25 years. The 
benefits of this 5-trial task include rapid assessment of delay discounting rates and minimal 
computing requirements. These advantages are particularly important given the online 
research context wherein time is limited and data collection is constrained by the 
participant’s computer equipment.
Participants completed up to three different versions of the task. All participants completed a 
traditional monetary delay task, with $1000 available delayed versus $500 available now. All 
cannabis-using participants also completed a cannabis delay discounting task, with 1 ounce 
of typical quality cannabis available delayed versus ½ ounce available now. Any participant 
endorsing current alcohol use also completed an alcohol delay task, with 24 US standard 
drinks available delayed versus 12 drinks available now (standard drink: one 12 oz. beer, 5 
oz. wine, or 1.5 oz. shot/mixed drink). These commodity amounts were within ranges used 
in previous alcohol and cannabis delay discounting studies (Johnson et al. 2010; Petry, 
2001). All delay discounting tasks included a statement emphasizing that consumption was 
not constrained by time and that the hypothetical goods could be kept.
2.2.2 Commodity Purchase Tasks—Commodity purchase tasks were used to evaluate 
behavioral economic demand for cannabis and alcohol. The same scenario was used in each 
task and all purchasing situations were framed as hypothetical in the present tense. 
Participants were asked to imagine a typical day over the last month when they used the 
commodity. They were told that they could only get the commodity from this source, had no 
commodity saved or kept from previous days, could not stockpile, and would have to 
consume all purchases in a single day. Participants were then asked how many drinks 
(alcohol) or hits (cannabis) they would purchase at 13 monetary increments ranging from 
$0.00 [free] to $11/unit, presented sequentially. This price range was selected due to its 
similarity to price ranges used in recent commodity purchase task studies (Amlung et al., 
2015a; Aston et al., 2015, 2016; Murphy et al., 2015). Alcohol drinks were described as one 
US standard drink. Cannabis hits were quantified as 0.09 g of average quality cannabis (i.e., 
10 hits = 1 joint or 0.9 g or 1/32nd of an ounce) consistent with previous literature (Aston et 
al., 2015). All cannabis-using participants completed the commodity purchase task for 
cannabis (Marijuana Purchase Task [MPT]; note the term Marijuana Purchase Task [MPT] is 
used to avoid confusion with the commonly used Cigarette Purchase Task [CPT]) and all 
participants endorsing current alcohol use the task for alcohol (Alcohol Purchase Task; 
APT).
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2.2.3 Drug Use Variables—A written version of the Mini-International Neuropsychiatric 
Interview (MINI) was used to evaluate cannabis dependence (CD) through endorsement of 
statements indicative of DSM-IV criteria (Sheehan et al., 1998). A Cannabis History and 
Smoking Questionnaire included questions about age of use onset, cannabis use patterns, 
and routes of administration (e.g., Aston et al., 2015; Metrik et al., 2009). Cannabis use 
variables included use severity (number of DSM-IV CD symptoms endorsed), frequency 
(percentage past month use days), and quantity (grams used per week), consistent with 
previous delay and demand literature (Aston et al., 2016). Other relevant drug use variables 
and demographics, such as age and the Fagerström Test for Nicotine Dependence (FTND), 
were also measured.
2.3 Data Analysis
Delay discounting rates (k values) were calculated by taking the inverse of ED50 values 
derived from the 5-trial adjusting delay task (Koffarnus and Bickel, 2014). Delay 
discounting rates were log-transformed prior to analysis to obtain normality. Demand curves 
were first evaluated for inattentive data or non-systematic curves using standard criteria (see 
details in Stein et al., 2015). Briefly, curves were evaluated for increased consumption with 
increased price, frequent price-to-price consumption increases, or reversals from zero 
consumption as well as extreme consumption (i.e., greater than 100 drinks or hits [9 grams 
of cannabis] in one day). Nine cannabis curves (14.1%) and 16 alcohol curves (15.7%) were 
determined non-systematic/inattentive and removed from demand analysis. Price elasticity 
and intensity were generated using the exponentiated demand equation:
where Q = consumption; Q0 = derived intensity of demand (consumption at zero price); k = 
a constant that denotes consumption range in log units (a priori set to 2); C = the price of the 
commodity; and α = derived elasticity of demand. The exponentiated model is a recently 
developed and validated equation that allows for the inclusion of zero consumption values 
(Koffarnus et al., 2015; Strickland et al., 2016b). Area under the curve (AUC) values were 
also generated as described previously (Amlung et al., 2015b; Aston et al., 2016). Briefly, 
the total area was operationalized as the AUC value when the maximum consumption value 
across the sample was inputted for each price (100 for both the MPT and APT). 
Proportionate AUC values were then generated by dividing each participants raw AUC by 
this total AUC (range = 0.0 to 1.0). Recent reports have proposed AUC as a single demand 
metric that is useful and valid measure to minimize repeated testing with multiple demand 
metrics and to allow for convergence with other behavioral economic measures (Amlung et 
al., 2015b; Aston et al., 2016). All demand metrics were log-transformed to correct for skew.
Demographic and drug use variables for cannabis users and controls were compared using 
independent sample t-tests. Independent sample t-tests were also used to compare monetary 
delay discounting as well as alcohol delay discounting and demand between groups. The 
relationship between cannabis use and demographic, demand, and delay discounting 
variables was first described using bivariate correlations in the cannabis-using group. The 
independent contribution of demand and delay discounting for predicting cannabis use was 
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then determined using multiple regression models. Consistent with previous studies (Aston 
et al., 2016), AUC was first used to quantify demand in these analyses. Follow up analyses 
were then conducted using demand intensity and elasticity in place of AUC. Additional tests 
were also conducted controlling for age, sex, income, and cigarette use (given the close 
association between cigarette use and delay discounting; Bickel et al., 1999; Johnson et al., 
2007). Only cannabis-using participants with all demand and delay discounting variables 
were included in regression analysis (n = 46 with complete data). All tests were conducted 
using SPSS 24 and GraphPad Prism 6.0 with a type I error rate of .05.
3. Results
3.1 Between-Group Comparisons
3.1.1 Demographics and Drug Use—Individuals reporting cannabis use were younger 
and more likely to report recent cigarette and alcohol use (i.e., in the past two weeks). 
Cannabis users also reported more drinking days per week and alcoholic drinks per week. 
Other demographic variables (e.g., race, income) did not differ between groups (Table 1).
3.1.2 Delay Discounting—Raw monetary, cannabis, and alcohol delay discounting rates 
are presented in Table 2. Monetary delay discounting did not differ between cannabis users 
and control (t134 = 0.52, p = .60). Similarly, alcohol delay discounting did not differ between 
these groups (t100 = 0.38, p = .70). No differences in the magnitude or significance of these 
findings were observed after controlling for relevant covariates (e.g., age, cigarette use, 
alcohol use).
3.1.3 Drug Demand—Demand curves for the MPT and APT showed prototypical 
decreases in consumption with increases in price for both groups (Figure 1). The 
exponentiated demand equation provided an excellent fit to group data (MPT: R2 = .99; 
APT: Cannabis Users R2 = .98, Controls R2 = .98) as well as individual curves (MPT: 
median R2 = .95, IQR = .91 to .97; APT: median R2 = .87, IQR = .79 to .93). No between-
group differences were observed for alcohol AUC (t85 = 0.39, p = .70). Similarly, no 
differences were observed for alcohol demand intensity (t85 = 0.50, p = .62) or elasticity (t85 
= 0.51, p = .61). No changes in the magnitude or significance of these comparisons between 
cannabis users and controls were observed in covariate analyses.
3.2 Drug Use Prediction in Cannabis Users
3.2.1 Bivariate Relationships—Bivariate relationships among drug demand, delay 
discounting variables, and self-reported drug use in cannabis users are presented in Table 3. 
Cannabis AUC was significantly and positively related to grams of cannabis used per week 
(r = .45, p = .001), percentage past month use days (r = .31, p = .02), and number of CD 
symptoms endorsed (r = .42, p = .001). Similar bivariate associations were observed for 
cannabis demand intensity and elasticity (Supplemental Table 1). Cannabis delay 
discounting was related to grams of cannabis used per week (r = .38, p = .002) and number 
of CD symptoms endorsed (r = .44, p < .001).
Strickland et al. Page 7
Behav Processes. Author manuscript; available in PMC 2018 July 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Intercorrelations between delay discounting and AUC revealed three significant associations 
all involving cannabis delay discounting. Cannabis delay discounting was significantly and 
positively related to cannabis demand (r = .34, p = .01), monetary delay discounting (r = .42, 
p = .001), and alcohol delay discounting (r = .33, p = .01).
3.2.2 Regression Models—Results from three regression models evaluating the unique 
prediction of cannabis use by AUC and delay discounting variables are presented in Table 4. 
Cannabis delay discounting was uniquely associated with the number of CD symptoms 
endorsed (sr2 = .16). The model predicting percentage of past month use days indicated a 
significant independent effect of cannabis AUC (sr2 = .09), but not alcohol AUC or delay 
discounting variables. A significant unique effect of cannabis AUC was also observed in the 
model predicting grams of cannabis used per week (sr2 = .12). Models including additional 
covariates (e.g., age, cigarette use) revealed outcomes similar in magnitude and significance. 
Cannabis AUC by delay discounting interactions were not significant when tested.
Additional models were used to determine if the association between cannabis use behaviors 
and behavioral economic demand was related to demand intensity (Q0) and/or elasticity (α). 
Models including demand intensity and elasticity revealed a similar pattern of effects as the 
AUC analysis, with cannabis demand intensity uniquely contributing to cannabis use 
frequency and quantity and cannabis delay discounting uniquely contributing to use severity 
(Table 5). Specifically, cannabis demand intensity was significantly and positively related to 
use quantity (sr2 = .29) and frequency (sr2 = .19). Alcohol demand intensity also showed an 
inverse relationship with grams of cannabis used per week (sr2 = .15).
4. Discussion
The primary finding of the present study was that cannabis delay discounting uniquely 
predicted use severity (i.e., CD symptom count), whereas cannabis demand uniquely 
predicted use frequency (i.e., past month use days) and quantity (i.e. grams used per week) 
in regression models. Follow-up analyses indicated that the primary behavioral mechanism 
contributing to the relationship between behavioral economic demand and cannabis use 
frequency and quantity was demand intensity. These findings are consistent with the only 
other study to evaluate the unique contribution of cannabis delay discounting and demand to 
cannabis use behaviors (Aston et al., 2016). Several methodological concerns potentially 
limited the generalizability of this aforementioned study, including the use of an exclusively 
White sample, low prevalence of CD symptoms, and data collection following placebo 
cannabis self-administration that may have influenced reported delay discounting outcomes 
(see Metrik et al., 2009, 2012 for discussion of cannabis expectancies). Our findings suggest 
that these experimental parameters did not contribute to the observed relationships and that 
the unique contribution of delay discounting and demand to cannabis use outcomes likely 
generalizes to diverse experimental settings and populations. Replication studies such as this 
one are particularly important given recent challenges the psychological and behavioral 
sciences have faced regarding reproducibility (Nosek et al., 2015; Open Source Data 
Collection, 2015).
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A consistency across online and in-laboratory samples also strengthens the case for the use 
of online sampling techniques to evaluate substance-using populations and behavioral 
mechanisms related to drug use (Koffarnus et al., 2015; Rass et al., 2015; Strickland et al., 
2016a). The use of crowdsourcing comes with many benefits including increased geographic 
and demographic variability, targeted recruitment of hard-to-reach populations, and a 
relative cost and time efficiency. A requisite step for using crowdsourcing, however, is the 
validation of findings across Internet and laboratory settings. This is particularly important 
for addiction research given that drug use cannot be biologically verified in participants 
online. The current study adds to the extant literature demonstrating similar outcomes across 
in-laboratory and online samples (e.g., Johnson et al., 2015; Strickland et al., 2016a), 
thereby supporting the validity of the crowdsourcing approach. These findings are 
particularly exciting as they offer a method by which findings can be replicated across 
diverse samples using sampling methods that provide complementary benefits and 
limitations.
In addition to replicating associations involving cannabis demand and delay discounting in 
this novel sample, this study extends previous findings in at least three ways. First, cannabis 
and alcohol demand and delay discounting measures were used to determine if the observed 
relationships were specific to cannabis. Alcohol was selected given the extensive literature 
validating the alcohol purchase task, the common use of alcohol in the general population, 
and the expectation that alcohol use should not uniquely associate with elevated cannabis 
use frequency, quantity, or severity. Cannabis demand and delay discounting specifically 
contributed to these cannabis use variables, even after controlling for the contribution of 
another common drug commodity (i.e., alcohol). Alcohol demand intensity was related to 
cannabis use quantity when testing demand intensity and elasticity measures; however, this 
relationship was not observed at the bivariate level and was smaller than the relationship 
involving cannabis demand intensity in the multiple regression model. Although monetary 
delay discounting was related to CD symptom count at the bivariate level, consistent with 
previous findings (Aston et al., 2016), the association was not unique or significant when 
controlling for the cannabis commodity relationship. These outcomes indicate that these 
behavioral economic relationships do not likely represent a general propensity to respond in 
a non-specific manner to the task requirements. Instead, they suggest that these relationships 
with drug use outcomes are specific to drug of interest, in this case cannabis.
Second, a quantity measure was included in addition to the frequency and severity measures 
previously evaluated. Similar outcomes as the frequency measure were observed, wherein 
cannabis demand uniquely predicted the quantity of cannabis use above and beyond other 
demand and delay discounting measures. This distinction is important given that cannabis 
use frequency and quantity represent unique dimensions of use patterns and can provide 
unique prediction of cannabis-related problems (Zeisser et al., 2012). Third, the recently 
developed 5-trial adjusting delay task was used, which allowed for rapid (~ 1 minute) 
generation of delay discounting rates. Prior research has validated this task by revealing a 
close relationship between this rapid task and traditional adjusting delay tasks (Cox and 
Dallery, 2016; Koffarnus and Bickel, 2014). To our knowledge, this is the first use of drug 
commodities, namely alcohol and cannabis, with this rapid delay discounting task. That the 
relationship between monetary, alcohol, and cannabis delay discounting rates and drug use 
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outcomes were generally significant and in the expected direction provides further support 
for use of this rapid assessment task in substance use research. The more complex 
relationships involving delay discounting (i.e., multiple regression analyses) were also 
consistent with previous findings (Aston et al., 2016), further supporting the validity of this 
delay discounting task and its future use.
Secondary analyses that focused on differences in delay discounting and demand variables 
between cannabis-users and non-using controls were also conducted given the limited 
research comparing these groups on these measures. Significant differences in monetary 
delay discounting as a function of cannabis use status were not observed, although this 
outcome is generally consistent with previous research (e.g., Johnson et al., 2010). 
Differences in alcohol delay discounting or demand were also not detected among cannabis 
users and controls. These outcomes remained after controlling for potentially important 
covariates, such as age or cigarette use, suggesting that the failure to detect differences was 
not due to low power or imbalances in relevant demographics. Taken together, these findings 
suggest that alterations in delay discounting and demand may not capture between-group 
differences in the likelihood of reporting current cannabis use. Instead, these measures may 
reflect differences in the propensity to use cannabis in a maladaptive or clinically relevant 
manner.
These findings should be considered within the context of their limitations. First, a large 
proportion of subjects were excluded due to inattentive or non-systematic data. This rate is 
generally consistent with previous mTurk research (e.g., Johnson et al., 2015) but is a 
limitation of conducting online research, and underscores the need to verify response fidelity 
due to decreased experimental control. Second, all participants completed the demand 
measures first followed by the delay discounting measures, and completed monetary delay 
discounting prior to drug tasks. Although this non-random completion order did not likely 
alter study outcomes, additional research would be needed for confirmation. Third, as noted 
above, cannabis use in the cannabis-using group was not biologically verified. However, the 
use of rigorous internal control measures and the consistency between this study and the 
previous laboratory one (Aston et al., 2016) supports the integrity of the data collected and 
outcomes reported. Fourth, participants were not asked about how much money they 
typically spent on cannabis. Because participants reported 50 or more lifetime uses, they 
were likely at least familiar with cannabis pricing. Fifth, the 5-trial delay discounting task 
did not permit examination of underlying orderliness in the raw data like traditional delay 
discounting tasks. However, the use of rigorous manipulation checks to evaluate participant 
attention and response fidelity helped to offset this limitation. Despite these potential 
limitations, this study replicates and extends previous research uniquely relating delay 
discounting and behavioral economic demand variables with cannabis use. This study also 
demonstrates the ability of online crowdsourcing to complement standard human laboratory 
procedures, thereby enhancing the overall rigor of research methods used to examine 
behavioral mechanisms of drug use disorders.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Behavioral economic demand (left panels) and expenditure (right panels) for cannabis (top 
panels) and alcohol (bottom panels). Participants completed commodity purchase tasks in 
which hypothetical cannabis (one hit quantified as 0.09 g) or alcohol (one US standard 
drink) were available. Price varied in United States dollars (USD). Plotted are mean (SEM) 
group data on a log-log axis fit using the exponentiated model. Squares and solid lines 
represent cannabis users (n = 55 for cannabis demand and 50 for alcohol demand) and 
circles and the dotted lines represent controls (n = 37 for alcohol demand).
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Table 1
Demographics and Drug Use Variables
Cannabis User (n = 64) Control (n = 72)
pMean (SD)/% Mean (SD)/%
Demographics
Age 30.2 (7.3) 33.7 (9.9)
.02*
Male 48.4% 44.4% .73
White 74.2% 75.0% .99
College Education 50.0% 65.3% .08
Household Income $41094 ($28122) $43889 ($28756) .57
Cannabis Use
Ever Use 100.0% 34.7% -
Lifetime Use 5810 (21166) 0.8 (1.7) -
% Month Use Days 63.7% (34.4%) 0% -
Grams/Week 6.4 (7.1) - -
# CD Symptoms 2.0 (2.1) - -
Other Drug Use
CIG Use 60.9% 15.3%
.001***
 FTNDa 3.9 (2.6) 4.0 (3.0) .88
ALC Use 85.9% 59.7%
.001**
 Drinks/Weekb 9.2 (14.4) 3.7 (7.8) .03*
 Drinking Days/Weekb 2.5 (2.0) 1.6 (1.4) .01*
 Heavy Use Daysb 72.7% 41.9% .003**
Note. CIG Use = cigarette use in the past two weeks determined from study screener; ALC Use = alcohol use in the past two weeks determined 
from study screener; # CD Symptoms = number of cannabis use dependence symptoms endorsed; FTND = Fagerström Test for Nicotine 
Dependence; Heavy Use Days = number of past month heavy alcohol use days (5 or more [males] or 4 or more [females] drinks in a single day).
aVariable only for participants reporting cigarette use in the past two weeks (n = 39 Cannabis Users; n = 11 Controls)
bVariable only for participants reporting alcohol use in the past two weeks (n = 55 Cannabis Users; n = 43 Controls)
*p < .05;
**p < .01;
***p < .001
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